SEC Form 4 · accession 0001144204-16-089000
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pete Bantock
Officer — CHIEF COMMERCIAL OFFICER
Period of report
Mar 18, 2016
Accepted (ET)
Mar 18, 2016 · 9:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $12.49 | Mar 18, 2016 | A | 4,120 | A | Mar 18, 2017 | Mar 18, 2026 | Common Stock | 4,120 | 219,173 | D |
Explanation of responses
- F1Option vests on the first anniversary of the date of grant.